|
"liu th"的相關文件
顯示項目 11-35 / 63 (共3頁)
1 2 3 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2025-02-12 |
D-amino acid oxidase correlation with neurofilament light chain in covid-infectedpatients
|
Liu, YL;Liu, TH;Wang, CH;Kuo, HW;Huang, SF;Tsou, HH;Chen, WJ |
| 國家衛生研究院 |
2025-01-10 |
Plasma neurofilament light chain levels are associated with delirium tremens in patients with alcohol use disorder
|
Hou, YC;Bavato, F;Liu, TH;Chang, HM;Kuo, HW;Meng, SC;Liu, YL;Huang, MC |
| 國家衛生研究院 |
2024-11 |
Psychometric evaluation of the Chinese version of alcohol relapse risk scale (C-ARRS) in patients with alcohol use disorder
|
Lee, IT;Liao, PC;Liu, TH;Ogai, Y;Chang, HM;Liu, YL;Huang, MC |
| 國家衛生研究院 |
2024-10-30 |
Association of bone turnover markers and craving reduction in patients with alcohol use disorder during withdrawal: Exploring the role of bone-brain axis
|
Tsao, HM;Huang, MC;Liu, TH;Chang, HM;Chung, RH;Kuo, HW;Chen, ACH;Yang, RS;Liu, YL |
| 國家衛生研究院 |
2024-10-21 |
Plasma leptin levels are lower in females, but not males, with ketamine use disorder
|
Huang, MC;Chiang, LJ;Chien, WH;Liu, TH;Chen, CH;Liu, YL |
| 國家衛生研究院 |
2024-10 |
Ketamine-dependent patients with persistent psychosis have higher neurofilament light chain levels than patients with schizophrenia
|
Chung, AN;Huang, MC;Liu, TH;Chang, HM;Chen, PY;Liu, YL;Bavato, F |
| 國家衛生研究院 |
2024-08-28 |
Clinical outcomes and histologic findings of patients with hepatocellular carcinoma with durable partial response or durable stable disease after receiving atezolizumab plus bevacizumab
|
Shen, YC;Liu, TH;Nicholas, A;Soyama, A;Yuan, CT;Chen, TC;Eguchi, S;Yoshizumi, T;Itoh, S;Nakamura, N;Kosaka, H;Kaibori, M;Ishii, T;Hatano, E;Ogawa, C;Naganuma, A;Kakizaki, S;Cheng, CH;Lin, PT;Su, YY;Chuang, CH;Lu, LC;Wu, CJ;Wang, HW;Rau, KM;Hsu, CH;Lin, SM;Huang, YH;Hernandez, S;Finn, RS;Kudo, M;Cheng, AL |
| 國家衛生研究院 |
2024-02-01 |
Outcomes of post-immunotherapy durable responders of advanced hepatocellular carcinoma- with emphasis on locoregional therapy for oligoprogression
|
Liu, TH;Chen, SC;Rau, KM;Lu, LC;Lin, PT;Su, YY;Teng, W;Lai, SW;Yeh, RH;Kao, TM;Lee, PC;Wu, CJ;Chen, CH;Hsu, CH;Lin, SM;Huang, YH;Chen, LT;Cheng, AL;Shen, YC |
| 國家衛生研究院 |
2023-06-14 |
Changes of neurofilament light chain in patients with alcohol dependence following withdrawal and the genetic effect from ALDH2 Polymorphism
|
Huang, MC;Tu, HY;Chung, RH;Kuo, HW;Liu, TH;Chen, CH;Mochly-Rosen, D;Liu, YL |
| 國家衛生研究院 |
2023-02 |
Comorbidity of ketamine dependence with major depressive disorder increases the vulnerability to neuroaxonal pathology
|
Huang, MC;Chen, CH;Liu, TH;Chung, AN;Liu, YL;Quednow, BB;Bavato, F |
| 國家衛生研究院 |
2023-01 |
Splice-site variants in the gene encoding GABA-A receptor delta subunit are associated with amphetamine use in patients under methadone maintenance treatment
|
Lin, YF;Chou, WH;Liu, TH;Fang, CP;Kuo, HW;Kuo, PH;Tsai, SJ;Wang, SC;Chung, RH;Tsou, HH;Chen, ACH;Liu, YL |
| 國家衛生研究院 |
2022-10 |
Outcomes of post-immunotherapy durable responders of advanced hepatocellular carcinoma - with emphasis on locoregional therapy for oligoprogression
|
Liu, TH;Chen, SC;Rau, KM;Lu, LC;Lin, PT;Su, YY;Teng, W;Lai, SW;Yehn, RH;Kao, TM;Lee, PC;Wu, CJ;Chen, CH;Hsu, CH;Lin, SM;Huang, YH;Chen, LT;Cheng, AL;Shen, YC |
| 國家衛生研究院 |
2022-07 |
Potential roles of gut microbiome in patients with hepatocellular carcinoma treated with immune checkpoint inhibitors
|
Su, YY;Lee, WH;Wang, JH;Wang, HW;Chen, TW;Chen, BB;Ho, HJ;Liu, TH;Chou, SC;Chen, BR;Liu, TW;Chen, LT;Wu, CY;Hsu, C |
| 國家衛生研究院 |
2022-01-04 |
Association of the D-amino acid oxidase gene with methadone dose in heroin dependent patients under methadone maintenance treatment
|
Liu, TH;Tsou, HH;Chung, RH;Liu, SC;Wang, SC;Kuo, HW;Fang, CP;Chen, ACH;Liu, YL |
| 國家衛生研究院 |
2022-01 |
Increase in plasma CCL11 (Eotaxin-1) in patients with alcohol dependence and changes during detoxification
|
Huang, MC;Chung, RH;Lin, PH;Kuo, HW;Liu, TH;Chen, YY;Chen, ACH;Liu, YL |
| 國家衛生研究院 |
2021-12 |
Validation of the EQ-5D in Taiwan using item response theory
|
Liu, TH;Ho, AD;Hsu, YT;Hsu, CC |
| 國家衛生研究院 |
2021-07-22 |
Increased Nectin-4 levels in chronic ketamine abusers and the relationship with lower urinary tract symptoms
|
Chang, HM;Chen, PY;Fang, CP;Liu, TH;Wu, CT;Hsu, YC;Kuo, HW;Liu, YL;Huang, MC |
| 國家衛生研究院 |
2021-03-30 |
Neurofilament light chain as novel blood biomarker of disturbed neuroaxonal integrity in patients with ketamine dependence
|
Liu, YL;Bavato, F;Chung, AN;Liu, TH;Chen, YL;Huang, MC;Quednow, BB |
| 國家衛生研究院 |
2020-10-22 |
CUX2, BRAP and ALDH2 are associated with metabolic traits in people with excessive alcohol consumption
|
Chen, IC;Kuo, PH;Yang, AC;Tsai, SJ;Liu, TH;Liu, HJ;Lan, TH;Chen, HM;Huang, HN;Chung, RH;Liu, YL |
| 國家衛生研究院 |
2020-06-18 |
Genetic variants in NECTIN4 encoding an adhesion molecule are associated with continued opioid use
|
Fang, CP;Liu, TH;Chung, RH;Tsou, HH;Kuo, HW;Wang, SC;Liu, CC;Liu, SC;Chen, ACH;Liu, YL |
| 國家衛生研究院 |
2020-04 |
Genetic polymorphisms in the opioid receptor delta 1 (OPRD1) gene are associated with methadone dose in methadone maintenance treatment for heroin dependence
|
Fang, CP;Wang, SC;Tsou, HH;Chung, RH;Hsu, YT;Liu, SC;Kuo, HW;Liu, TH;Chen, ACH;Liu, YL |
| 國家衛生研究院 |
2019-10-24 |
Serum level and activity of butylcholinesterase: A biomarker for post-stroke dementia
|
Chen, YC;Chou, WH;Fang, CP;Liu, TH;Tsou, HH;Wang, Y;Liu, YL |
| 國家衛生研究院 |
2019-08 |
Genomewide sex-by-snp interaction scan identifies adgrv1 for the sex differences of opioid dependence in african american and supporting evidence in relations with treatment side effects in the asian population
|
Yang, BZ;Zhou, H;Cheng, ZS;Liu, TH;Chung, RH;Kranzler, H;Wang, SC;Farrer, L;Liu, YL;Gelernter, J |
| 國立交通大學 |
2019-04-02T05:59:46Z |
2-V-operation delta-doped power HEMT's for personal handy-phone systems
|
Lai, YL; Chang, EY; Chang, CY; Liu, TH; Wang, SP; Hsu, HT |
| 國立交通大學 |
2019-04-02T05:59:23Z |
5 mm high-power-density dual-delta-doped power HEMT's for 3 V L-band applications
|
Lai, YL; Chang, EY; Chang, CY; Chen, TK; Liu, TH; Wang, SP; Chen, TH; Lee, CT |
顯示項目 11-35 / 63 (共3頁)
1 2 3 > >>
每頁顯示[10|25|50]項目
|
